TY - JOUR
T1 - Incidence of Convexal Subarachnoid Hemorrhage in the Elderly
T2 - The Mayo Clinic Study of Aging
AU - Yost, Micah
AU - Fiebelkorn, Catherine Arnold
AU - Rabinstein, Alejandro A.
AU - Klaas, James
AU - Aakre, Jeremiah A.
AU - Brown, Robert D.
AU - Mielke, Michelle M.
AU - Knopman, David S.
AU - Lowe, Val
AU - Petersen, Ronald C.
AU - Jack, Clifford R.
AU - Vemuri, Prashanthi
AU - Graff-Radford, Jonathan
N1 - Funding Information:
Grant Support: National Institute on Aging grants K76 AG057015-02, R01 AG011378, R01 AG041851, U01 AG06786 Mayo Clinic Study of Aging (MCSA), and R01 AG034676 Rochester Epidemiology Project (REP); National Institute of Neurological Disorders and Stroke R01 NS097495.
Funding Information:
VJL – reports consulting for Bayer Schering Pharma, Merck Research, and Piramal Imaging Inc and receives research support from GE Healthcare , Siemens Molecular Imaging, AVID Radiopharmaceuticals , the NIH ( National Institute on Aging , National Cancer Institute ), the Elsie and Marvin Dekelboum Family Foundation, the Liston Family Foundation, and the MN Partnership for Biotechnology and Medical Genomics. CJ consults for Eli Lilly and serves on an independent data monitoring board for Roche but he receives no personal compensation from any commercial entity. He receives research support from NIH and the Alexander Family Alzheimer's Disease Research Professorship of the Mayo Clinic . D.S.K. serves on a data safety monitoring board for the DIAN study. He is an investigator in clinical trials sponsored by Lilly Pharmaceuticals , Biogen , and the Alzheimer's Treatment and Research Institute at USC, and receives research support from NIH. AAR - receives royalties from Elsevier and Oxford University Press and has received research support from DJO Global, Inc. Mi.M.M. is a consultant for Eli Lilly and Lysosomal Therapeutics and receives unrestricted research grants from Biogen, Lundbeck, and Roche, and research funding from NIH/NIA and the US Department of Defense. P.V. receives NIH funding. R.C.P. is a consultant for Roche, Biogen, Merck, Eli Lilly, and Genentech. He receives publishing royalties from Mild Cognitive Impairment ( Oxford University Press , 2003) and research support from NIH. J.G-R. receives research funding from NIA/NIH. MY, JAA, CAF, RDB, AAR report no disclosures.
Publisher Copyright:
© 2019 Elsevier Inc.
PY - 2019/12
Y1 - 2019/12
N2 - Objectives: Nontraumatic convexal subarachnoid hemorrhages in the elderly can be a manifestation of cerebral amyloid angiopathy associated with a high risk of future intracerebral hemorrhage. The incidence in the elderly population is unknown. Our objectives were to: 1) determine the incidence of convexal subarachnoid hemorrhage in a population-based study, and, 2) to compare apopolipoprotein-E genotype and amyloid positron emission tomographic (PET) imaging for those with versus without hemorrhage. Methods: Between 11/29/2004 and 3/11/2017, 4462 individuals without hemorrhage at baseline participated in the population-based Mayo Clinic Study of Aging. We used the Rochester Epidemiology Project medical records-linkage system to identify intracerebral hemorrhages. Records and images were reviewed to identify convexal subarachnoid hemorrhage. Neuroimaging characteristics, demographics, medications, and apopolipoprotein-E genotype were recorded. Results: Four cases were identified. The incidence of convexal subarachnoid hemorrhage was 14.1 per 100,000 person years. Three occurred in women, median age, 79 (range: 71-84). One patient had coexisting cerebral microbleeds. Two participants developed a subsequent lobar intracerebral hemorrhage at a median of 4.75 years after convexal subarachnoid hemorrhage. The apopolipoprotein-E -allele combinations of the 4 were: 3/3, 3/3, 2/2, and 2/3. On Pittsburgh Compound B-PET imaging, median standardized uptake value ratio with convexal subarachnoid hemorrhage was 1.86 (range: 1.38-2.34). Conclusions: Convexal subarachnoid hemorrhage is rare in the older population, occurring with an incidence of about 14 per 100,000 person years. Yet, when present, it may be associated with a high risk of future intracerebral hemorrhage.
AB - Objectives: Nontraumatic convexal subarachnoid hemorrhages in the elderly can be a manifestation of cerebral amyloid angiopathy associated with a high risk of future intracerebral hemorrhage. The incidence in the elderly population is unknown. Our objectives were to: 1) determine the incidence of convexal subarachnoid hemorrhage in a population-based study, and, 2) to compare apopolipoprotein-E genotype and amyloid positron emission tomographic (PET) imaging for those with versus without hemorrhage. Methods: Between 11/29/2004 and 3/11/2017, 4462 individuals without hemorrhage at baseline participated in the population-based Mayo Clinic Study of Aging. We used the Rochester Epidemiology Project medical records-linkage system to identify intracerebral hemorrhages. Records and images were reviewed to identify convexal subarachnoid hemorrhage. Neuroimaging characteristics, demographics, medications, and apopolipoprotein-E genotype were recorded. Results: Four cases were identified. The incidence of convexal subarachnoid hemorrhage was 14.1 per 100,000 person years. Three occurred in women, median age, 79 (range: 71-84). One patient had coexisting cerebral microbleeds. Two participants developed a subsequent lobar intracerebral hemorrhage at a median of 4.75 years after convexal subarachnoid hemorrhage. The apopolipoprotein-E -allele combinations of the 4 were: 3/3, 3/3, 2/2, and 2/3. On Pittsburgh Compound B-PET imaging, median standardized uptake value ratio with convexal subarachnoid hemorrhage was 1.86 (range: 1.38-2.34). Conclusions: Convexal subarachnoid hemorrhage is rare in the older population, occurring with an incidence of about 14 per 100,000 person years. Yet, when present, it may be associated with a high risk of future intracerebral hemorrhage.
KW - Convexal subarachnoid hemorrhage
KW - amyloid PiB PET
KW - apopolipoprotein-E (APOE) e2
KW - cerebral amyloid angiopathy
KW - convexity subarachnoid hemorrhage
UR - http://www.scopus.com/inward/record.url?scp=85074386598&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85074386598&partnerID=8YFLogxK
U2 - 10.1016/j.jstrokecerebrovasdis.2019.104451
DO - 10.1016/j.jstrokecerebrovasdis.2019.104451
M3 - Article
C2 - 31668581
AN - SCOPUS:85074386598
SN - 1052-3057
VL - 28
JO - Journal of Stroke and Cerebrovascular Diseases
JF - Journal of Stroke and Cerebrovascular Diseases
IS - 12
M1 - 104451
ER -